David Borkholder is the Bausch and Lomb Professor of Microsystems Engineering at the Rochester Institute of Technology. He holds adjunct appointments with the University of Rochester departments of Otolaryngology and Biomedical Engineering. Prof Borkholder received the BS degree in Microelectronic Engineering from RIT, and the MS and PhD degrees in Electrical Engineering from Stanford University. He has trained at the Marine Biological Laboratory at Woods Hole on the biology of the inner ear. The Borkholder Laboratory works on a variety of projects in biosensors, MEMs, medical devices, additive manufacturing, and therapies for auditory dysfunction. His work on soldier borne blast dosimetry resulted in fielding of the Blast Gauge technology in Afghanistan, providing a new capability and new class of data to aid in triage and treatment of traumatic brain injuries. This sensor system is now produced by BlackBox Biometrics; a company he founded and where he serves as the Chief Technology Officer. Prof Borkholder also co-founded Heart Health Intelligence, a spin-out company from his laboratory which is commercializing technologies for non-invasive cardiovascular assessment. Prof Borkholder has published numerous articles in technical, educational, and medical literature and holds several patents related to cell-based biosensors, DNA analysis, blast dosimetry, and cardiovascular monitoring. He served on the DARPA Defense Sciences Research Council (DSRC) from 2009 through 2015 and is a former Chair of the NIH Bioengineering of Neuroscience, Vision, and Low Vision Technologies (BNVT) study section. Prior to joining RIT, Dr. Borkholder served as the Director of Hardware Engineering at ZONARE Medical Systems, Inc. where he led electronics and ASIC development for a portable premium quality ultrasound system. At Cepheid, he served as the Director of Electronic Systems and Technical Lead, developing automated systems for DNA extraction and analysis. His doctoral thesis focused on cell based biosensors using microelectrodes for chemical warfare agent detection and pharmaceutical screening.